miércoles, 7 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 27, 2026

This Software Company Is Betting $25 Billion That Its Stock Is Severely Undervalued Right Now

View original at nasdaq.com
This Software Company Is Betting $25 Billion That Its Stock Is Severely Undervalued Right Now Key Points Slowing revenue growth and AI fears have cut this stock's earnings multiple over the last few years…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Management expects enterprise adoption of AI to increase token usage, creating opportunity to sell additional credits or unlimited access while keeping prices stable as cost per token declines

    60% confidence

  • Management expects to produce an adjusted operating margin around 40% by fiscal 2030, resulting in average operating income growth of around 15.5% over the next four years

    60% confidence

  • Management expects investors to see revenue acceleration in the second half of 2027, sooner than previously anticipated

    60% confidence

  • The 10 best stocks for investors to buy now do not include Salesforce

    60% confidence

  • Total annual recurring revenue tied to AI efforts (Agentforce, Data 360, and Informatica cloud) stood at $2.9 billion as of the end of the year

    60% confidence

  • The highest-quality SaaS companies with wide moats could find AI more of a friend than a foe, making the current sell-off a massive buying opportunity

    60% confidence

  • Management sees potential for AI to expand addressable market as agentic capabilities increase ROI, encouraging more companies to buy more licenses

    60% confidence

  • Stock Advisor's total average return is 898%, compared to 182% for the S&P 500

    60% confidence

  • Revenue will climb to $63 billion by fiscal 2030, implying annualized revenue growth of 11% over the next four years

    60% confidence

  • Agentforce sales increased 169% year over year to $800 million last quarter

    60% confidence

  • Net new annual order value (AOV) growth increased in the second half of fiscal 2026 relative to the second half of 2025

    60% confidence

Data points we hold from this source

Salesforce · ev to ebitda10 multiple
Salesforce · annual recurring revenue ai2.9 USD
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
This Software Company Is Betting $25 Billion That Its Stock Is Severely Undervalued Right Now — Source | Via News | es.VIA.NEWS